Bacteremia in human immunodeficiency virus-infected children in Cape Town, South Africa
- PMID: 21572372
- DOI: 10.1097/INF.0b013e318220a68b
Bacteremia in human immunodeficiency virus-infected children in Cape Town, South Africa
Abstract
Bacteremia contributes to morbidity of HIV-infected children. In a randomized controlled trial evaluating trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis, 47 bacteremias were detected. The incidence rate of bacteremia increased in the first 3 months after starting combination antiretroviral therapy (cART), but decreased by 74% once children were established on cART for more than 3 months. Children should be prioritized for early cART.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
